Advances in Cancer and Virus-Host Cell Interactions
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 582
Special Issue Editors
Interests: oncology; monobody; siRNA; lung cancer
Interests: pancreatic cancer; triple-negative breast cancer; HPV-mediated cervical cancers; kinases in cancer, drug discovery
Special Issue Information
Dear Colleagues,
Cancer is a complex and multifactorial disease that involves genetic, epigenetic, environmental, and lifestyle factors. Among these factors, viral infection is an indisputable causal factor for nearly 17% of all human cancers. Viruses can cause cancer by various mechanisms. However, the diversity and complexity of oncogenic mechanisms raise new questions as to the mechanistic role of viruses in cancer initiation, progression, and therapy.
The aim of this Special Issue is to provide a comprehensive and updated overview of the current knowledge and challenges in the field of cancer and virus–host cell interactions.
We welcome contributions from researchers working on different types of viruses that are linked to human cancers, such as human papillomaviruses (HPVs), hepatitis viruses B and C (HBV and HCV), human gammaherpesviruses (HHV4/Epstein–Barr Virus (EBV) and HHV8/Kaposi's Sarcoma-Associated Herpesvirus (KSHV), Merkel cell polyomavirus (MCPyV), and human T-cell leukemia virus I (HTLV-1). We also encourage submissions that explore the interactions between viruses and other factors that influence cancer development, such as genetics, epigenetics, immunity, metabolism, microbiome, etc.
The scope of this Special Issue is to provide a platform for researchers to share their latest findings and insights on the complex interplay between cancer and virus–host cell interactions. We hope that this Special Issue will stimulate further research and collaboration in this important and rapidly evolving field of biomedicine.
Dr. Mubashir Javed Mintoo
Dr. Rakesh Sathish Nair
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- virus
- HPV
- EBV
- immunity
- microbiome
- biomedicine
